Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| Redmile Group, LLC | Institution | 14.549.768 | 8,88% | US$ 79,30M | 2026-03-31 |
| BlackRock, Inc. | Institution | 10.938.509 | 6,68% | US$ 59,61M | 2026-03-31 |
| FMR LLC | Institution | 10.635.576 | 6,49% | US$ 57,96M | 2026-03-31 |
| Alerce Investment Management L.P. | Institution | 8.921.397 | 5,45% | US$ 48,62M | 2025-11-21 |
| BVF Partners L.P. | Institution | 8.698.173 | 5,31% | US$ 47,41M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 6.919.255 | 4,22% | US$ 37,71M | 2026-03-31 |
| Logos Global Master Fund, LP | Institution | 6.600.000 | 4,03% | US$ 35,97M | 2025-04-21 |
| Vanguard Capital Management, LLC | Institution | 5.956.589 | 3,64% | US$ 32,46M | 2026-03-31 |
| Bain Capital Life Sciences Investors, LLC | Institution | 5.212.674 | 3,18% | US$ 28,41M | 2026-03-31 |
| Bellevue Asset Management AG | Institution | 5.157.290 | 3,15% | US$ 28,11M | 2026-03-31 |
| MAK Capital One, LLC | Institution | 4.724.043 | 2,88% | US$ 25,75M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 4.644.823 | 2,83% | US$ 25,31M | 2026-03-31 |
| Adage Capital Management, L.P. | Institution | 4.300.000 | 2,62% | US$ 23,44M | 2026-03-31 |
| Bank of America Corporation | Institution | 4.206.398 | 2,57% | US$ 22,92M | 2026-03-31 |
| Teachers Insurance and Annuity Association-College Retirement Equities Fund | Institution | 4.172.424 | 2,55% | US$ 22,74M | 2026-03-31 |
| Artal Group S.A. | Institution | 3.958.646 | 2,42% | US$ 21,57M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 3.886.909 | 2,37% | US$ 21,18M | 2026-03-31 |
| Columbia Management Investment Advisers, LLC | Institution | 3.449.121 | 2,11% | US$ 18,80M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 3.399.850 | 2,08% | US$ 18,53M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 3.377.823 | 2,06% | US$ 18,41M | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 3.114.314 | 1,90% | US$ 16,97M | 2026-03-31 |
| Palo Alto Investors LP | Institution | 2.948.090 | 1,80% | US$ 16,07M | 2026-03-31 |
| Morgan Stanley | Institution | 2.684.106 | 1,64% | US$ 14,63M | 2026-03-31 |
| Great Point Partners, LLC | Institution | 2.500.000 | 1,53% | US$ 13,63M | 2026-03-31 |
| Woodline Partners LP | Institution | 2.337.137 | 1,43% | US$ 12,74M | 2026-03-31 |
| Opaleye Management Inc. | Institution | 2.331.761 | 1,42% | US$ 12,71M | 2026-03-31 |
| Point72 Asset Management, L.P. | Institution | 1.871.795 | 1,14% | US$ 10,20M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 1.483.090 | 0,91% | US$ 8,08M | 2026-03-31 |
| UBS Asset Management AG | Institution | 1.376.588 | 0,84% | US$ 7,50M | 2026-03-31 |
| Y-Intercept (Hong Kong) Limited | Institution | 1.319.913 | 0,81% | US$ 7,19M | 2026-03-31 |
| Tetragon Partners UK LLP | Institution | 1.292.455 | 0,79% | US$ 7,04M | 2026-03-31 |
| Millennium Management LLC | Institution | 1.238.678 | 0,76% | US$ 6,75M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 1.226.601 | 0,75% | US$ 6,68M | 2026-03-31 |
| Satter Medical Technology Partners, L.P. | Institution | 1.147.738 | 0,70% | US$ 6,26M | 2025-11-21 |
| Charles Schwab Investment Management, Inc. | Institution | 1.102.445 | 0,67% | US$ 6,01M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 1.086.902 | 0,66% | US$ 5,92M | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
